| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
|
Emerg Infect Dis
|
2002
|
2.76
|
|
2
|
Advances in the development of vaccines against Neisseria meningitidis.
|
N Engl J Med
|
2010
|
1.99
|
|
3
|
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.
|
Clin Diagn Lab Immunol
|
2003
|
1.38
|
|
4
|
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.
|
J Infect Dis
|
2010
|
1.35
|
|
5
|
E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.
|
Microb Pathog
|
2007
|
1.28
|
|
6
|
Comparison of four polymerase chain reaction assays for specificity in the identification of Streptococcus pneumoniae.
|
Diagn Microbiol Infect Dis
|
2004
|
1.25
|
|
7
|
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
|
Vaccine
|
2007
|
1.17
|
|
8
|
Differentiation of Streptococcus pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
|
Appl Environ Microbiol
|
2008
|
1.16
|
|
9
|
Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens.
|
Bioinformatics
|
2004
|
1.14
|
|
10
|
Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions.
|
J Clin Microbiol
|
2004
|
1.14
|
|
11
|
Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
|
J Infect Dis
|
2006
|
1.11
|
|
12
|
Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides.
|
Clin Vaccine Immunol
|
2010
|
1.09
|
|
13
|
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.
|
Immun Ageing
|
2005
|
1.09
|
|
14
|
A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.
|
Microb Pathog
|
2007
|
1.07
|
|
15
|
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.
|
Clin Vaccine Immunol
|
2012
|
1.06
|
|
16
|
Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults.
|
Hum Vaccin
|
2006
|
1.05
|
|
17
|
Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays.
|
Am J Clin Pathol
|
2004
|
1.04
|
|
18
|
Pneumococcal surface adhesin A (PsaA): a review.
|
Crit Rev Microbiol
|
2008
|
1.04
|
|
19
|
Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.
|
Clin Diagn Lab Immunol
|
2004
|
1.03
|
|
20
|
Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells.
|
Microb Pathog
|
2007
|
1.01
|
|
21
|
A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.
|
J Infect Dis
|
2009
|
1.00
|
|
22
|
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.
|
Clin Vaccine Immunol
|
2010
|
0.99
|
|
23
|
Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation.
|
Vaccine
|
2005
|
0.99
|
|
24
|
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
|
Clin Diagn Lab Immunol
|
2004
|
0.98
|
|
25
|
Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.
|
Vaccine
|
2006
|
0.98
|
|
26
|
Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A.
|
Clin Diagn Lab Immunol
|
2005
|
0.98
|
|
27
|
Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.
|
Clin Vaccine Immunol
|
2009
|
0.97
|
|
28
|
Assignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992.
|
Clin Diagn Lab Immunol
|
2002
|
0.97
|
|
29
|
Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.
|
Clin Vaccine Immunol
|
2007
|
0.97
|
|
30
|
Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.
|
Clin Diagn Lab Immunol
|
2003
|
0.97
|
|
31
|
Haemophilus influenzae type a infection and its prevention.
|
Infect Immun
|
2007
|
0.97
|
|
32
|
Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.
|
Clin Vaccine Immunol
|
2006
|
0.94
|
|
33
|
Statistical considerations for vaccine immunogenicity trials. Part 1: Introduction and bioassay design and analysis.
|
Vaccine
|
2005
|
0.94
|
|
34
|
Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively.
|
J Trauma
|
2002
|
0.93
|
|
35
|
Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.
|
Clin Diagn Lab Immunol
|
2005
|
0.92
|
|
36
|
Retracted
Pneumococcal surface adhesin A (PsaA): a review.
|
Crit Rev Microbiol
|
2008
|
0.92
|
|
37
|
Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.
|
J Infect Dis
|
2002
|
0.91
|
|
38
|
Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.
|
Clin Diagn Lab Immunol
|
2005
|
0.91
|
|
39
|
P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.
|
Clin Vaccine Immunol
|
2010
|
0.88
|
|
40
|
A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.
|
Int J Microbiol
|
2011
|
0.88
|
|
41
|
An augmented passive immune therapy to treat fulminant bacterial infections.
|
Recent Pat Antiinfect Drug Discov
|
2010
|
0.87
|
|
42
|
Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.
|
Clin Diagn Lab Immunol
|
2002
|
0.87
|
|
43
|
Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.
|
Vaccine
|
2009
|
0.86
|
|
44
|
Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.
|
Clin Vaccine Immunol
|
2010
|
0.85
|
|
45
|
Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.
|
Clin Diagn Lab Immunol
|
2002
|
0.85
|
|
46
|
Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.
|
Vaccine
|
2010
|
0.83
|
|
47
|
An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditions.
|
J Microbiol Methods
|
2007
|
0.81
|
|
48
|
Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.
|
Clin Vaccine Immunol
|
2006
|
0.80
|
|
49
|
Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.
|
Pediatr Infect Dis J
|
2012
|
0.80
|
|
50
|
Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells.
|
BMC Genomics
|
2013
|
0.80
|
|
51
|
A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms.
|
J Proteomics
|
2012
|
0.80
|
|
52
|
Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection.
|
BMC Genomics
|
2013
|
0.78
|
|
53
|
Absence of high molecular weight proteins 1 and/or 2 is associated with decreased adherence among non-typeable Haemophilus influenzae clinical isolates.
|
J Med Microbiol
|
2013
|
0.78
|
|
54
|
A real-time polymerase chain reaction for the detection of Streptococcus pneumoniae in blood using a mouse model: a potential new "gold standard".
|
Diagn Microbiol Infect Dis
|
2008
|
0.77
|
|
55
|
Analysis of recombinant acylated pneumococcal surface adhesin A of Streptococcus pneumoniae by mass spectrometry.
|
Arch Biochem Biophys
|
2003
|
0.76
|
|
56
|
Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.
|
Antimicrob Agents Chemother
|
2013
|
0.76
|